Replies to post #246 on Synta Pharmaceuticals Corp. (SNTA)

[biomanbaba]

players are loading their boats for this

As previously announced, Synta intends to complete a second interim analysis of the Phase 2b portion of the GALAXY trial in Q3 2012. Results are planned for presentation at the September 28 – October 2 2012 meeting of the European Society for Medical Oncology (ESMO). Synta also plans to meet with regulatory agencies and transition to the Phase 3 portion of the GALAXY trial before the end of this year.